Company Filing History:
Years Active: 1995-1996
Title: Glenn J Samuels: Innovator in Pharmaceutical Formulations
Introduction
Glenn J Samuels is a notable inventor based in Sunnyvale, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of high dose formulations. With a total of 3 patents, his work has advanced the manufacturing processes of important medications.
Latest Patents
Samuels' latest patents include innovative formulations for mycophenolate mofetil and mycophenolic acid. These patents describe methods for conveniently manufacturing high dose oral formulations through the hot melt filling of supercooled liquids into pharmaceutical dosage forms. Additionally, he has developed high dose ranolazine formulations, which also utilize similar manufacturing techniques. These advancements are crucial for improving the efficacy and convenience of oral medications.
Career Highlights
Glenn J Samuels is currently associated with Syntex (U.S.A.) Inc., where he continues to push the boundaries of pharmaceutical innovation. His expertise in formulation science has positioned him as a key player in the industry, contributing to the development of effective therapeutic solutions.
Collaborations
Throughout his career, Samuels has collaborated with esteemed colleagues, including Jung-Chung Lee and Charles Lee. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Glenn J Samuels exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations have paved the way for advancements in medication formulations. His work continues to impact the field positively.